This inventor holds 2 USPTO granted patents and 1 published patent application, plus 2 CIPO patents and 1 EPO patent. Top assignee: Axon Biochemicals B.v.. Active years: 2007-2008.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2007-2008
Title: Per Erik Andren: Innovator in Aporphine Derivatives
Introduction
Per Erik Andren is a notable inventor based in Uppsala, Sweden. He has made significant contributions to the field of pharmaceuticals, particularly in the development of new therapeutic agents. With a total of 2 patents to his name, Andren's work focuses on innovative solutions for various medical conditions.
Latest Patents
Andren's latest patents include groundbreaking research on aporphine esters and their therapeutic applications. These new aporphine derivatives, which are described by a specific formula, have shown potential in treating Parkinson's disease, hemicrania, restless legs syndrome (RLS), sexual dysfunction in both men and women, hyperprolactinemia, and psychotic disorders. Additionally, the patents detail processes for the preparation of these derivatives, highlighting their importance in the evaluation and treatment of Parkinson's disease.
Career Highlights
Throughout his career, Andren has worked with several prominent companies, including Axon Biochemicals B.V. and Denator AB. His experience in these organizations has allowed him to collaborate with other experts in the field and contribute to significant advancements in medical research.
Collaborations
Andren has collaborated with notable professionals such as Hakan Wikstrom and Durk Dijkstra. These partnerships have further enriched his research and development efforts, leading to innovative solutions in the pharmaceutical industry.
Conclusion
Per Erik Andren's contributions to the field of pharmaceuticals, particularly through his patents on aporphine derivatives, demonstrate his commitment to advancing medical science. His work continues to have a positive impact on the treatment of various health conditions.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile